Researchers determine causes of fatigue in breast cancer patients



Women who are recovering from breast cancer and buy Tamoxifen to reduce their risk of a recurrence often experience fatigue. While some studies have indicated that the medication may be partially to blame, a new investigation suggests other factors are likely involved as well.

Women who are recovering from breast cancer and buy Tamoxifen to reduce their risk of a recurrence often experience fatigue. While some studies have indicated that the medication may be partially to blame, a new investigation suggests other factors are likely involved as well.

After surveying 59 patients recovering from cancer, researchers from the University of Granada in Spain found that those who had depression, body image problems and neck, shoulder and arm pain were the most likely to experience fatigue.

The researchers said the findings could provide doctors with better knowledge of which patients are most likely to experience fatigue following treatment for breast cancer. This may contribute to better therapeutic strategies that allow individuals to get back to their normal lives.

"These findings should motivate patient support programmes which improve their psychological condition and offer resources that can reduce pain," said lead researcher Manuel Arroyo. "If fatigue is not treated, patients can suffer it for years, having a serious physical, emotional, social and economic impact."

The study did not necessarily rule out Tamoxifen as a potential cause of fatigue, but it did suggest other factors are important as well.